Theriva™ Biologics to Participate in the BIO-Europe Spring Conference
March 11, 2024 08:00 ET ROCKVILLE, Md., March 11, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that Company’s Management will provide a corporate update and participate in one-on-one meetings at the BIO-Europe […]
Theriva™ Biologics to Participate in the BIO-Europe Spring Conference Read More »